Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events - FINESSE

Description:

The goal of the trial was to evaluate percutaneous coronary intervention (PCI) facilitated by abciximab with half-dose thrombolytic (reteplase), abciximab alone, or placebo among patients with ST-elevation myocardial infarction (STEMI).